Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder
Álex Iranzo, Angela Mammana, Amaia Muñoz‐Lopetegi, et al.
Neurology (2023) Vol. 100, Iss. 18
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Clinical effects of Lewy body pathology in cognitively impaired individuals
Corinne Quadalti, Sebastian Palmqvist, Sara Hall, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1964-1970
Open Access | Times Cited: 81
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies
Christopher H. Gibbons, Todd Levine, Charles H. Adler, et al.
JAMA (2024) Vol. 331, Iss. 15, pp. 1298-1298
Open Access | Times Cited: 68
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease
Shijun Yan, Cheng Jiang, Annette Janzen, et al.
JAMA Neurology (2023) Vol. 81, Iss. 1, pp. 59-59
Open Access | Times Cited: 50
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden
Giuseppe Mario Bentivenga, Angela Mammana, Simone Baiardi, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 37
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease
Kathrin Brockmann, Stefanie Lerche, Simone Baiardi, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 29
Detecting Misfolded α‐Synuclein in Blood Years before the Diagnosis of Parkinson's Disease
Annika Kluge, Eva Schaeffer, Josina Bunk, et al.
Movement Disorders (2024) Vol. 39, Iss. 8, pp. 1289-1299
Open Access | Times Cited: 25
Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease
Maria Tsalenchuk, Steve Gentleman, Sarah J. Marzi
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification
Angela Mammana, Simone Baiardi, Marcello Rossi, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 10, pp. 2001-2010
Open Access | Times Cited: 15
α‐Synuclein seed amplification assay detects Lewy body co‐pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden
Johannes Levin, Simone Baiardi, Corinne Quadalti, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 6, pp. 4351-4365
Open Access | Times Cited: 14
Parkinson disease therapy: current strategies and future research priorities
Fabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 12, pp. 695-707
Closed Access | Times Cited: 13
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease
Lorenzo Barba, Samir Abu‐Rumeileh, Henryk Barthel, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3325-3343
Closed Access | Times Cited: 11
α-Synuclein seed amplification technology for Parkinson’s disease and related synucleinopathies
Claudio Soto
Trends in biotechnology (2024) Vol. 42, Iss. 7, pp. 829-841
Closed Access | Times Cited: 10
Sleep and sleep disorders in people with Parkinson's disease
Álex Iranzo, Valérie Cochen De Cock, María Livia Fantini, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 9, pp. 925-937
Closed Access | Times Cited: 9
A skin-specific α-Synuclein seeding amplification assay for diagnosing Parkinson’s disease
Yaoyun Kuang, Hengxu Mao, Tingting Gan, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases
David S. Goldstein, Parvez Alam, Patti Sullivan, et al.
Movement Disorders Clinical Practice (2025)
Closed Access | Times Cited: 1
Toward a biological definition of neuronal and glial synucleinopathies
Claudio Soto, Brit Mollenhauer, Oskar Hansson, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 1
Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Dietmar Rudolf Thal, Koen Poesen, Rik Vandenberghe, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Fluid and Biopsy Based Biomarkers in Parkinson's Disease
David G. Coughlin, David J. Irwin
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 932-954
Open Access | Times Cited: 21
What's in a Name? The Time Has Come to Unify Parkinson's Disease and Dementia with Lewy Bodies
Daniel Weintraub
Movement Disorders (2023) Vol. 38, Iss. 11, pp. 1977-1981
Closed Access | Times Cited: 18
Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies
Juan Huang, Xingxing Yuan, Lin Chen, et al.
Experimental Gerontology (2024) Vol. 187, pp. 112366-112366
Open Access | Times Cited: 7
Biomarkers of neurodegeneration in isolated and antidepressant‐related rapid eye movement sleep behavior disorder
Francesco Biscarini, Fabio Pizza, Stefano Vandi, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 6
Open Access | Times Cited: 7
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies
David G. Coughlin, Karen MacLeod, John S. Middleton, et al.
Neurology (2024) Vol. 103, Iss. 3
Closed Access | Times Cited: 6
Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions
Félix Javier Jiménez‐Jiménez, Hortensia Alonso‐Navarro, Elena García‐Martín, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1263-1263
Open Access | Times Cited: 16
Opportunities and Pitfalls of REM Sleep Behavior Disorder and Olfactory Dysfunction as Early Markers in Parkinson’s Disease
Beatrice Orso, Sarah Brosse, Johannes Frasnelli, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S275-S285
Open Access | Times Cited: 6
Pain in Parkinson’s disease: a neuroanatomy-based approach
Domiziana Nardelli, Francesco Gambioli, M Bartolo, et al.
Brain Communications (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top